Search

everythinglearnresearchcommunity

for

Search:↓

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Substance from human umbilical cord blood cells promotes hair growth.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Researchers made two new compounds that could be used for medicine.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Antioxidants might help prevent pressure ulcers, but more research is needed to find effective ones.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Rotterdam Study aims to understand various diseases in older adults.